{{Rsnum
|rsid=2166775
|Gene=SLC9A9
|Chromosome=3
|position=143785691
|Orientation=plus
|GMAF=0.3926
|Gene_s=SLC9A9
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 16.9 | 43.1 | 40.0
| HCB | 64.4 | 28.9 | 6.7
| JPT | 47.7 | 47.7 | 4.5
| YRI | 82.5 | 17.5 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 64.4 | 28.9 | 6.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22566498
|Trait=None
|Title=Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker.
|RiskAllele=G
|Pval=0.000003
|OR=0.9900
|ORtxt=None
|OA=1
}}

{{on chip | FTDNA}}